Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma cells to MDM2 inhibitorsChien-Tsung Liu(National Health Research Institutes), Li-Tzong Chen(Kaohsiung Medical University)Research SquareJune 3, 202510.21203/rs.3.rs-6489065/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersPhase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers|OncoImmunology|2021|44